Resources A modular in-vessel cell retention device enables perfusion fermentation across diverse bioprocesses | Sunflower Application Note read more Perfusion fermentation in the Daisy Petal™ bioreactor sustains ultra-high biomass | Sunflower Application Note read more Daisy Petal™ simplifies fermentation optimization | Sunflower Application Note read more Improving Production of Recombinant Proteins through Yeast Strain Engineering | Sunflower Application Note read more Video 1: Introduction to the Daisy Petal Perfusion Bioreactor System read more Video 2: Installing the Single Use Assembly read more Video 3: Introduction to the Sunflower Software Suite read more Daisy Petal™ Specification Sheet read more Perfusion fermentation in the Daisy Petal™ bioreactor | Sunflower Application Note read more Chemically Defined Media for Yeast | Sunflower Application Note read more « Older Entries Publications Characterization of a Potential Therapeutic Anti-Canine PD-1 Single Domain Antibody Produced in Yeast Jul 8, 2025 Perfusion fermentation sets a path to democratize biomanufacturing Dec 1, 2024 Adaptation of aglycosylated monoclonal antibodies for improved production in Komagataella phaffii Nov 14, 2024 Minimal purification method enables developability assessment of recombinant proteins Mar 17, 2023 Equitable drug access: small-scale manufacturing units can help Sep 26, 2022 Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffii Nov 15, 2021 Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice Sep 7, 2021 Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus May 1, 2021 Rapid optimization of processes for the integrated purification of biopharmaceuticals Mar 30, 2021 Alternative hosts as the missing link for equitable therapeutic protein production Mar 11, 2021 Development of a platform process for the production and purification of single‐domain antibodies Feb 22, 2021 On-demand manufacturing of clinical-quality biopharmaceuticals | Nature Biotechnology Oct 5, 2018 The yeast stands alone: the future of protein biologic production | Current Opinion in Biotechnology Dec 10, 2017
A modular in-vessel cell retention device enables perfusion fermentation across diverse bioprocesses | Sunflower Application Note read more
Perfusion fermentation in the Daisy Petal™ bioreactor sustains ultra-high biomass | Sunflower Application Note read more
Improving Production of Recombinant Proteins through Yeast Strain Engineering | Sunflower Application Note read more
Characterization of a Potential Therapeutic Anti-Canine PD-1 Single Domain Antibody Produced in Yeast Jul 8, 2025
Adaptation of aglycosylated monoclonal antibodies for improved production in Komagataella phaffii Nov 14, 2024
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffii Nov 15, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice Sep 7, 2021
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus May 1, 2021
Development of a platform process for the production and purification of single‐domain antibodies Feb 22, 2021
The yeast stands alone: the future of protein biologic production | Current Opinion in Biotechnology Dec 10, 2017
